REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Nasdaq operates securities markets in Stockholm, Copenhagen, Helsinki and Iceland. These Nasdaq Nordic Markets which are jointly called the Nasdaq Nordic Main Market are classified as Regulated ...

Alvotech will conduct a business update conference call and live webcast on Thursday March 27, 2025, at 8:00 am ET (12:00pm ...

TORONTO, ONTARIO – 21 March 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land package of gold and strategic mineral ...

Headquartered in Reykjavik, Iceland, Alvotech’s shares are listed on Nasdaq Iceland and Nasdaq US. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality ...

Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...

Nasdaq Stockholm AB, Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd, Nasdaq Iceland hf, Nasdaq Oslo ASA, Nasdaq Tallinn AS, Nasdaq Riga AS and AB Nasdaq Vilnius (“Nasdaq”) does not guarantee that ...

Reykjavík, March 21, 2025 (GLOBE NEWSWIRE) -- (“Amaroq Minerals ” or the “Company ”) Notice of Results and Investor Presentation TORONTO, ONTARIO – 21 March 2025 – Amaroq Minerals Ltd. (AIM, TSXV, ...

Alvotech REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar ...